2016
DOI: 10.1007/s10120-016-0661-x
|View full text |Cite
|
Sign up to set email alerts
|

Early detection of nonperitoneal recurrence may contribute to survival benefit after curative gastrectomy for gastric cancer

Abstract: Background There is no evidence that strict follow-up using cross-sectional imaging after curative gastrectomy benefits survival; however, nonperitoneal recurrence detected early might be treated with additional surgery. The present study examined whether early detection of recurrence by imaging modalities could increase survival, particularly in patients with nonperitoneal recurrence. Methods We retrospectively analyzed 218 patients with recurrent gastric cancer after curative gastrectomy performed from 2002 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 26 publications
0
12
0
Order By: Relevance
“…In 2016, Fujiya et al[50] retrospectively analyzed 218 patients with recurrent gastric cancer after curative gastrectomy. The patients were divided into an asymptomatic group ( n = 117) and a symptomatic group ( n = 101).…”
Section: What Is the Evidence?mentioning
confidence: 99%
“…In 2016, Fujiya et al[50] retrospectively analyzed 218 patients with recurrent gastric cancer after curative gastrectomy. The patients were divided into an asymptomatic group ( n = 117) and a symptomatic group ( n = 101).…”
Section: What Is the Evidence?mentioning
confidence: 99%
“…On the other hand, it was reported that early detection of stomach carcinoma recurrence may be associated with improved survival because it may provide an opportunity for the treatment to be initiated while the patient's condition is sufficiently stable to receive effective therapy, including resection of recurrence site and chemotherapy (D'Ugo et al 2013). The detection of non-peritoneal recurrence before the appearance of symptoms may provide survival benefit, because additional surgery at the site of recurrence can be performed (Fujiya et al 2017). Clinically resectable cases of liver metastasis from stomach carcinoma are rare, but in the 256 patients undergoing hepatic resection, the 5-year overall survival rate was 31.1% (Kinoshita et al 2015).…”
Section: Discussionmentioning
confidence: 99%
“…For example, patients with a high BPM score will be recommended to receive postoperative multimodality treatment, such as chemotherapy, immunotherapy, and targeted therapy. And more regular follow-up schedule will be offered to early detect recurrence, which may provide survival benefit[41]. A patient example of how the model can be used in clinical practice is provided in the .…”
Section: Discussionmentioning
confidence: 99%